The Australian pharmaceutical industry landscape is set to change dramatically as a result of government changes to the Pharmaceutical Benefits Scheme (PBS), says a new report.
Following Parliamentary approval last November of the National Health Amendment (Pharmaceutical Benefits Scheme) Bill of 2010, which aims to make savings of around A$1.9 billion over five years, the outlook for the future includes withdrawn products, a struggling generics industry and reorganisation within the wholesaling sector, warns the study, from Datamonitor.
via pharmatimes.com
No comments:
Post a Comment